Preimplantation Genetic Testing Market Size is expected to reach USD 2.2 billion by 2034

• Preimplantation genetic testing market was estimated to be worth USD 0.8 billion in 2023, and during the 2024–2034 forecast period, it is expected to grow at a compound annual growth rate (CAGR) of 12.5% to reach USD 2.2 billion.
• By choosing embryos devoid of genetic defects, preimplantation genetic testing dramatically raises the likelihood of a fruitful pregnancy and the birth of a healthy kid. The market is increasing and sustainable since it is in line with the healthcare industry.
• Procedures involving assisted reproductive technology (ART) now include this technology as a necessary component. The process entails examining embryos for distinct genetic disorders or chromosomal irregularities to guarantee that solely sound embryos are inserted into the uterus.

?

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preimplantation-genetic-testing-market

?

GROWTH DRIVERS

• One of the main factors propelling the market is the rise in the prevalence of chromosomal abnormalities and genetic disorders. In developed nations, congenital anomalies and genetic illnesses may account for as much as 50% of childhood fatalities.
• Additionally, up to 30% of pediatric hospital hospitalizations may be related to these illnesses. An estimated 240 000 infants worldwide pass away from congenital diseases within 28 days of birth each year.
• The substantial growth in government health spending across all national income levels is responsible for the surge in health spending to a record high of USD 9 trillion, or over 11% of the world's gross domestic product. The promotion of PGT was greatly aided by the activism of patient groups and professional associations.

MARKET SEGMENTATION:

·?????????By Product & Services- reagent and consumables, instruments, software and services

·?????????By Procedure Type- Preimplantation Genetic Diagnosis & Preimplantation Genetic Screening

·?????????By Technology- Next-Generation Sequencing, Fluorescence In-Situ Hybridization, Polymerase Chain Reaction, Comparative Genomic Hybridization and Single-Nucleotide Polymorphism

·?????????By Application- Structural Chromosomal Abnormalities (Translocations, Deletions, Inversions, Duplication), Aneuploidy, Gender Identification, Single Gene Disorders, X-Linked Disorders, HLA Typing

·?????????By Type of Cycle- Fresh Donor, Fresh Non- Donor, Frozen Donor, Frozen Non-Donor

·?????????By End-User- Hospitals, Diagnostic Laboratories, Fertility Clinics

·?????????By Region-?North America, Europe, Asia Pacific, The Middle East and Africa, South America

Global Key Players:

·?????????Illumina, Inc.

·?????????Thermo Fisher Scientific Inc.

·?????????CooperSurgical, Inc.

·?????????Agilent Technologies, Inc.

·?????????Revvity

·?????????Abbott

·?????????Takara Bio, Inc.

·?????????Qiagen

·?????????Vitrolife

·?????????Oxford Nanopore Technologies

·?????????Bioarray S.L.

·?????????Other Players

?

For More Information about this Report @ https://www.xresearch.biz/shop/preimplantation-genetic-testing-market

??????????????????????????????????

Contact:???????????????????????????????????????????

Company Name:? xResearch

Contact Person:? James Lin

Email:? [email protected]

Phone:?+1 718-619-8140